Lygenesis, co-founded by Dr. Lagasse, receives FDA clearance Phase 2a Trials
January 13, 2021
January 13, 2021
Share
LyGenesis Inc, co-founded by PLRC’s Dr. Eric Lagasse, Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing.